Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility
October 06, 2017 11:00 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Oct. 06, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical Receives 510k Clearance for Expanded Indications of Irix-A
September 12, 2017 10:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical Reports Second Quarter 2017 Financial Results
August 09, 2017 17:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical Receives FDA Clearance for Calix-C Cervical Interbody Line Extension and Expanded Indications
August 09, 2017 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today...
Xtant Medical Joins the 2018 Donate Life Rose Parade Float to Highlight the Power of Organ, Eye, and Tissue Donation
August 03, 2017 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, is proud to...
Xtant Medical to Announce Second Quarter 2017 Results on August 9th, 2017
July 24, 2017 14:16 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., July 24, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant Medical Announces Rescheduling of Annual Meeting
May 26, 2017 16:00 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., May 26, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced...
Xtant Medical Enters into Licensing Agreement for Sites Medical’s OsteoSync Ti Technology
May 16, 2017 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., May 16, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and...
Xtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners
May 12, 2017 07:30 ET
|
Xtant Medical Holdings, Inc.
BELGRADE, Mont., May 12, 2017 (GLOBE NEWSWIRE) -- Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced it...
Xtant™ Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period
May 09, 2017 17:38 ET
|
Xtant Medical Holdings, Inc.
First Quarter 2017 Highlights: Consolidated total revenue increased 5.3% to $22.1 million compared to first quarter 2016 revenue of $21.0 millionConsolidated gross profit increased 10.1% to $15.5...